首页|和胃降逆胶囊对胃腺癌细胞凋亡的影响及其机制

和胃降逆胶囊对胃腺癌细胞凋亡的影响及其机制

扫码查看
目的 以核转录因子-κB/上皮间充质转化(NF-κB/EMT)信号通路为基础,探讨和胃降逆含药血清对胃腺癌AGS细胞增殖和凋亡的影响及作用机制.方法 制备不同药物剂量(3,6,12 g/kg)的和胃降逆含药血清,作为含药血清低、中、高剂量组,不含药物的血清作为空白对照组.采用不同药物剂量的和胃降逆含药血清分别干预AGS细胞24,48,72 h后,用CCK-8法观察细胞增殖;DAPI染色法检测细胞凋亡;划痕试验观察细胞迁移;实时定量聚合酶链反应法(RT-qPCR)检测NF-κB、EMT标志物相关蛋白E-钙黏蛋白(E-cadherin)、N-钙黏蛋白(N-cadherin)、波形蛋白(Vimentin)mRNA水平;蛋白免疫印迹法(Western blot)检测细胞内NF-κB、E-cadherin、Vimentin相关信号通路蛋白的表达.结果 同一时间点,与空白对照组比较,和胃降逆含药血清组细胞活力降低(P<0.01);同一含药血清剂量组48,72 h与24 h比较细胞活力降低(P<0.05).干预48 h,与空白对照组比较,不同剂量含药血清组AGS细胞凋亡率剂量依赖性增加(P<0.05).与空白对照组比较,和胃降逆含药血清组划痕愈合速度均减慢,迁移率降低(P<0.05);干预24 h,与空白对照组比较,高剂量组细胞迁移降低(P<0.01),干预48 h,中、高剂量组细胞迁移率降低(P<0.01).与空白对照组比较,和胃降逆含药血清组AGS细胞中NF-κB、Vimentin的mRNA水平剂量依赖性下调(P<0.05),E-cadherin的mRNA水平剂量依赖性上调(P<0.01).与空白对照组比较,和胃降逆含药血清组AGS细胞中NF-κB、Vimentin的蛋白表达剂量依赖性下调,E-cadherin的蛋白表达剂量依赖性上调(P<0.05).结论 和胃降逆胶囊可能通过抑制NF-κB活化、调控下游EMT相关蛋白的表达介导胃腺癌细胞AGS的迁移和侵袭,进而抑制AGS细胞增殖并促进其凋亡.
Effect of Hewei Jiangni capsules on apoptosis of gastric adenocarcinoma cells and its mechanism
Objective To observe the effects of serum containing Hewei Jiangni on proliferation and apoptosis of gastric cancer cells(AGS)and its mechanism based on NF-κB/EMT signaling pathway.Methods Serums containing low,medium,and high concen-trations of Hewei Jiangni(3,6,and 12 g/kg)were prepared,and the blank serum was used as control group.AGS cells were intervened with serums containing different concentrations of Hewei Jiangni for 24,48,72 h respectively.The proliferation of AGS cells was detected by CCK-8 kit.The apoptosis of AGS cells was detected by DAPI staining.The migration of AGS cells was observed by Scratch test.The mRNA levels of NF-κB and EMT marker proteins E-cadherin and Vimentin were detected by quantitative real-time polymerase chain reaction(RT-qPCR).The protein expressions of NF-κB,E-cadherin,and Vimentin were detected by Western blot.Results At the same time points,compared with control group,the viability of cells was dose-dependently decreased in Hewei Jiangni groups(P<0.01).Compared with 24 h,the viability of AGS cells was decreased in Hewei Jiangni groups at 48,72 h(P<0.05).At 48 h,compared with control group,the apoptosis of AGS cells was dose-dependently increased in Hewei Jiangni groups(P<0.05).Compared with control group,the scratch healing speed was slowed down,and the rate of cell migration was reduced in Hewei Jiangni groups(P<0.05).Compared with control group,the migration was decreased at 24 h in high dose group(P<0.01),and was also reduced at 48 h in medium and high dose groups(P<0.01).Compared with control group,the mRNA levels of NF-κB and Vimentin in AGS cells were dose-dependently downregulated in Hewei Jiangni groups(P<0.05),while E-cadherin mRNA was dose-dependently upregulated(P<0.01).Compared with control group,the protein levels of NF-κB and Vimentin in AGS cells were dose-dependently downregulated while the E-cadherin proein expression was dose-dependently upregulated in Hewei Jiangni groups(P<0.05).Conclusion Hewei Jiangni can mediate the migration and invasion of AGS cells by inhibiting the activation of NF-κB,and regulating the expressions of downstream EMT-related proteins,thus inhibiting the proliferation and promoting the apoptosis of AGS cells.

Hewei Jiangni capsulegastric cancerNF-κB/EMTE-cadherinVimentin

孙钟慧、窦建卫、唐锐、刘子源、潘振宇

展开 >

西安市第五医院药学部,西安 710082

西安交通大学医学部

中国人民解放军空军第986医院消化内科

西安市儿童医院药学部

展开 >

和胃降逆胶囊 胃腺癌 NF-κB/EMT E-cadherin Vimentin

陕西省重点研发计划项目西安市科技计划项目

2019SF-01322YXYJ0060

2024

山西医科大学学报
山西医科大学

山西医科大学学报

CSTPCD
影响因子:0.931
ISSN:1007-6611
年,卷(期):2024.55(8)